ATE527358T1 - Ribosomen inaktivierendes protein vom typ-1 - Google Patents

Ribosomen inaktivierendes protein vom typ-1

Info

Publication number
ATE527358T1
ATE527358T1 AT98928659T AT98928659T ATE527358T1 AT E527358 T1 ATE527358 T1 AT E527358T1 AT 98928659 T AT98928659 T AT 98928659T AT 98928659 T AT98928659 T AT 98928659T AT E527358 T1 ATE527358 T1 AT E527358T1
Authority
AT
Austria
Prior art keywords
protein
ribosome
inactivative
type
conjugate
Prior art date
Application number
AT98928659T
Other languages
English (en)
Inventor
Fiorenzo Stirpe
Andrea Bolognesi
Original Assignee
Pangenetics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenetics Bv filed Critical Pangenetics Bv
Application granted granted Critical
Publication of ATE527358T1 publication Critical patent/ATE527358T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98928659T 1997-06-06 1998-06-08 Ribosomen inaktivierendes protein vom typ-1 ATE527358T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201725 1997-06-06
PCT/NL1998/000336 WO1998055623A1 (en) 1997-06-06 1998-06-08 Type-1 ribosome-inactivating protein

Publications (1)

Publication Number Publication Date
ATE527358T1 true ATE527358T1 (de) 2011-10-15

Family

ID=8228417

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928659T ATE527358T1 (de) 1997-06-06 1998-06-08 Ribosomen inaktivierendes protein vom typ-1

Country Status (6)

Country Link
US (2) US6680296B1 (de)
EP (1) EP0975762B1 (de)
AT (1) ATE527358T1 (de)
AU (1) AU8040898A (de)
CA (1) CA2295189C (de)
WO (1) WO1998055623A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
KR20120053525A (ko) 2000-06-16 2012-05-25 캠브리지 안티바디 테크놀로지 리미티드 면역특이적으로 ＢＬｙＳ에 결합하는 항체
WO2002016411A2 (en) 2000-08-18 2002-02-28 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
AU2002238052A1 (en) 2001-02-20 2002-09-04 Zymogenetics, Inc. Antibodies that bind both bcma and taci
EP1241267A3 (de) * 2001-03-14 2004-01-02 Viscum AG Enzym-Aktivitätstest mittels fluoreszenzmarkierter Oligonukleotid-Substrate
ES2356307T3 (es) 2002-04-19 2011-04-06 Zymogenetics, L.L.C. Procedimientos para detectar o modular la interacción de un receptor de citocina con su ligando.
PT2829283T (pt) 2003-04-30 2017-09-08 Univ Zuerich Método para tratamento do cancro utilizando uma imunotoxina
CA2560278C (en) 2004-03-19 2012-11-20 Matthew Baker Modified bouganin proteins, cytotoxins and methods and uses thereof
NZ556055A (en) 2004-12-21 2009-12-24 Viventia Biotech Inc Cancer specific antibody and cell surface proteins
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
CA2684330A1 (en) 2007-04-19 2008-10-30 Viventia Biotech Inc. Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
CA2700815A1 (en) 2007-09-27 2009-04-02 Viventia Biotech Inc. Optimized nucleic acid sequences for the expression of vb4-845
CN102317313A (zh) * 2008-02-27 2012-01-11 柏尔科学公司 1型核糖体失活蛋白的制备和应用
WO2012093931A1 (en) * 2011-01-07 2012-07-12 Valiant Biopharma Sdn Bhd Antimicrobial fusion compounds and uses thereof
ES2747273T3 (es) 2013-10-02 2020-03-10 Viventia Bio Inc Anticuerpos anti-EpCAM y métodos de uso
CN107580501A (zh) 2015-03-12 2018-01-12 维文蒂亚生物公司 用于靶向epcam阳性膀胱癌的给药策略
EP3268040A4 (de) 2015-03-12 2018-09-12 Viventia Bio Inc. Verfahren zur behandlung von epcam-positivem blasenkrebs
US12274735B2 (en) 2017-10-10 2025-04-15 Medicenna Therapeutics Inc. IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255843A1 (en) * 1973-12-26 1975-07-25 Chatenoud Gilles Device for watering plants in window boxeseetc - has water container, wick, distributor and filler pipe
GB2095083A (en) 1981-03-20 1982-09-29 Fah Ah Ngau Automatic watering system for plants
DE3525266A1 (de) * 1985-07-16 1987-01-29 Zlatko Rajmund Fers Vorrichtung zum bewaessern von pflanzen und gestecken
FR2646750A1 (fr) 1989-05-09 1990-11-16 Stroppa Mauro Dispositif modulaire en kit a capacite variable a humidification capillaire permettant de transformer tout recipient quelconque en un bac a plantes a reserve d'eau
US5376546A (en) 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
EP0700444B1 (de) 1993-05-12 2003-04-02 XOMA Corporation Gelonin und einen antikörper entahltende immuntoxine
US5597569A (en) 1993-10-25 1997-01-28 Bristol-Myers Squibb Company Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica
US5535547A (en) * 1995-09-15 1996-07-16 Brunengo; P. John Conduit and float gauge apparatus

Also Published As

Publication number Publication date
CA2295189A1 (en) 1998-12-10
CA2295189C (en) 2010-11-23
EP0975762B1 (de) 2011-10-05
US7479552B2 (en) 2009-01-20
US6680296B1 (en) 2004-01-20
EP0975762A1 (de) 2000-02-02
US20040266994A1 (en) 2004-12-30
AU8040898A (en) 1998-12-21
WO1998055623A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
ATE527358T1 (de) Ribosomen inaktivierendes protein vom typ-1
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
PT730608E (pt) Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes
EA200001041A1 (ru) Антитела к cd23, их производные и их терапевтическое применение
NO901986D0 (no) Nytt antistoff-leveringssystem for biologisk respons-modifiserende midler.
PT912176E (pt) Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao
DE69632546D1 (de) Ob proteinderivate mit verlängerter halbwertzeit
TR199700610A3 (tr) Düsük molekül agirlikli çözünür, tümör nekroz faktörü tip-I ve tip-II proteinleri.
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
ATE365744T1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
ATE322503T1 (de) Gefrierschutzprotein
DE69731463D1 (de) Rekombinante ribonuklease proteine
ATE331728T1 (de) Proteinmarkierung mit radioaktivem phospor und gezielte radiotherapie
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
CA2265444A1 (en) Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
EA200001127A1 (ru) Бактериальные феромоны и их использование
DE69534753D1 (de) Nierenpolycystose-gen
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
EA199800819A1 (ru) Способ лечения биполярного расстройства
ATE255594T1 (de) Hepatitis b inhibitoren
DK0811068T3 (da) Humane DNase I varianter

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties